Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CRMX | 20.64 | 0.75 | +3.77% |
| Tradr 2X Long CRML Daily ETF (CRMX) | |||
| TMFX | 24.91 | 0.12 | +0.48% |
| Motley Fool Next Index ETF (TMFX) | |||
| YSEP | 28.43 | 0.11 | +0.39% |
| FT Vest International Equity Moderate Buffer ETF - September (YSEP) | |||
| USTB | 50.12 | 0.04 | +0.08% |
| VictoryShares Short-Term Bond ETF (USTB) | |||
| BSEP | 54.40 | -0.11 | -0.21% |
| Innovator U.S. Equity Buffer ETF - September (BSEP) | |||
Industry Biotechnology